Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Morris

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
CJC Open|September 23, 2022
Leber's Hereditary Optic Neuropathy and Hypertrophic CardiomyopathyThomas Morris Hey, Søren Kristian Nielsen, Ulrik Eriksen, et al.
Scientific Reports|July 23, 2024
Pain prevalence, intensity, and association with neuropsychiatric symptoms of dementia in immigrant and non-immigrant aged care residents in AustraliaPelden Chejor, Mustafa Atee, Patricia Cain, et al.
British Journal of Biomedical Science|May 4, 2023
UK Reference Intervals for Parathyroid Hormone Using Abbott MethodsMehdi Mirzazadeh, Craig Webster, Gayani Weerasinghe, et al.
Investigational New Drugs|September 19, 2009
A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancerWilliam R Schelman, Glenn Liu, George Wilding, et al.
Clinical Therapeutics|August 4, 2010
An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteersHelen K Tomkinson, John V Kemp, Thomas Wollseifen, et al.
Clinical Chemistry and Laboratory Medicine|June 23, 2026
Unwarranted variation in total B12 test thresholds for the diagnosis of vitamin B12 deficiency across the UK and the validation of a method-specific total B12 reference interval for the Beckman Coulter DxI platform to support implementation of NICE NG239Emma Stevenson, Rachel Marrington, Duncan Stevenson, et al.
Frontiers in Psychiatry|April 30, 2021
Evaluating the Clinical Impact of National Dementia Behaviour Support Programs on Neuropsychiatric Outcomes in AustraliaStephen Macfarlane, Mustafa Atee, Thomas Morris, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 12, 2014
A study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysisMiriam Lynn, Naisha Shah, Judith Conroy, et al.
BJU International|December 2, 2011
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 yearsPeter Iversen, David G McLeod, William A See, et al.
The Australian and New Zealand Journal of Psychiatry|February 22, 2022
Clinico-demographics of people with younger-onset dementia and neuropsychiatric symptoms referred to an Australian dementia support service: A comparison study with older-onset dementiaSamantha M Loi, Mustafa Atee, Thomas Morris, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
CJC Open|September 23, 2022
Leber's Hereditary Optic Neuropathy and Hypertrophic CardiomyopathyThomas Morris Hey, Søren Kristian Nielsen, Ulrik Eriksen, et al.
Scientific Reports|July 23, 2024
Pain prevalence, intensity, and association with neuropsychiatric symptoms of dementia in immigrant and non-immigrant aged care residents in AustraliaPelden Chejor, Mustafa Atee, Patricia Cain, et al.
British Journal of Biomedical Science|May 4, 2023
UK Reference Intervals for Parathyroid Hormone Using Abbott MethodsMehdi Mirzazadeh, Craig Webster, Gayani Weerasinghe, et al.
Investigational New Drugs|September 19, 2009
A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancerWilliam R Schelman, Glenn Liu, George Wilding, et al.
Clinical Therapeutics|August 4, 2010
An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteersHelen K Tomkinson, John V Kemp, Thomas Wollseifen, et al.
Clinical Chemistry and Laboratory Medicine|June 23, 2026
Unwarranted variation in total B12 test thresholds for the diagnosis of vitamin B12 deficiency across the UK and the validation of a method-specific total B12 reference interval for the Beckman Coulter DxI platform to support implementation of NICE NG239Emma Stevenson, Rachel Marrington, Duncan Stevenson, et al.
Frontiers in Psychiatry|April 30, 2021
Evaluating the Clinical Impact of National Dementia Behaviour Support Programs on Neuropsychiatric Outcomes in AustraliaStephen Macfarlane, Mustafa Atee, Thomas Morris, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 12, 2014
A study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysisMiriam Lynn, Naisha Shah, Judith Conroy, et al.
BJU International|December 2, 2011
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 yearsPeter Iversen, David G McLeod, William A See, et al.
The Australian and New Zealand Journal of Psychiatry|February 22, 2022
Clinico-demographics of people with younger-onset dementia and neuropsychiatric symptoms referred to an Australian dementia support service: A comparison study with older-onset dementiaSamantha M Loi, Mustafa Atee, Thomas Morris, et al.
Pageof 9